Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients

4 Mar 2019

Abstract excerpt

Olanzapine is a second-generation antipsychotic medication, which plays a predominant role in current treatment of schizophrenia. It has been observed that the olanzapine response in schizophrenia treatment is different across individuals. However, predicting such individual-specific olanzapine response requires deep understanding of relevant biomarkers. Here, we performed an integrative investigation on 238 Han...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Associations and Epidemiology
Share to Genomics and Rare Diseases
Share to Schizophrenia research and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30886581
DOI: 10.3389/fphar.2019.00177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia PatientsPMID 30886581Read ↗

Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.Semantic proximity Read ↗

Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.Semantic proximity Read ↗

The pharmacogenetics of treatment with olanzapineSemantic proximity Read ↗

Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population.Semantic proximity Read ↗

Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint studySemantic proximity Read ↗

Association of 5-HTR2A T102C and A-1438G polymorphisms with clinical response to atypical antipsychotic treatment in schizophrenia: A meta-analysis.Semantic proximity Read ↗

Interindividual Variability in Olanzapine Steady-State Concentrations in Chinese: Exploring Single Nucleotide Polymorphisms of Metabolic EnzymesSemantic proximity Read ↗

Psychosis susceptibility zinc finger protein 804A (ZNF804A) gene polymorphism in schizophrenia patients treated with olanzapine in North Indian population.Semantic proximity Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

An Effective Method to Facilitate Personalized and Precise Medicine for Schizophrenia Treatment Based on PharmacogenomicsSemantic proximity Read ↗

Effect of Genetic Variants, Gender, and Co-treatment on Olanzapine Plasma Concentration in Chinese patients with schizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.